Maciej Wiznerowicz

Poznan University of Medical Sciences — Poland

Biochemistry, Genetics and Molecular Biology · Life Sciences

86h-index78.8kcitations200works16.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(63), Virus-based gene therapy research(33), RNA modifications and cancer(22), RNA Interference and Gene Delivery(20), Ferroptosis and cancer prognosis(20)

Publications110 total

Immunohistological Examination of HEATR1 and SLC27A2 Expression in ccRCC Samples to Evaluate Their Potential as Prognostic Markers—A Preliminary Study
Cancers·2025Open Access
PROM1 and EFTUD2 Expression in High-Grade Clear Cell Renal Cell Carcinoma as a Molecular Marker for Survival Rate
International Journal of Molecular Sciences·2025Open Access
Prognostic Significance of Overexpression of BCL9 and TPX2 in High-Grade Clear Cell Renal Cell Carcinoma: Prognostic Markers for Metastasis and Survival
International Journal of Molecular Sciences·2025Open Access
Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets
Cell Genomics·2025· 3 citedOpen Access
Prognostic Significance of Elevated UCHL1, SNRNP200, and PAK4 Expression in High-Grade Clear Cell Renal Cell Carcinoma: Insights from LC-MS/MS Analysis and Immunohistochemical Validation
Cancers·2024· 1 citedOpen Access
Multi-scale signaling and tumor evolution in high-grade gliomas
Cancer Cell·2024· 39 citedOpen Access
Comprehensive proteogenomic characterization of rare kidney tumors
Cell Reports Medicine·2024· 39 citedOpen Access
Abstract LB004: Deciphering oncogenic dedifferentiation: A proteomic approach to quantifying stemness scores and unveiling druggable targets
Cancer Research·2024
Pan-cancer proteogenomics characterization of tumor immunity
Cell·2024· 76 citedOpen Access
EPCO-53. MULTI-SCALE REGULATION OF SIGNALING CASCADES AND TUMOR EVOLUTION IN HIGH GRADE ASTROCYTOMAS
Neuro-Oncology·2023Open Access
Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
Cancer Cell·2023· 90 citedOpen Access
Proteogenomic insights suggest druggable pathways in endometrial carcinoma
Cancer Cell·2023· 44 citedOpen Access
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer
Nature Cancer·2023· 69 citedOpen Access
Abstract LB061: Proteomic-based stemness score measure oncogenic dedifferentiation and enable the identification of druggable targets
Cancer Research·2023
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Cancer Cell·2022· 184 citedOpen Access
Disruption of RING and PHD Domains of TRIM28 Evokes Differentiation in Human iPSCs
Cells·2021· 9 citedOpen Access
Abstract 3113: Pan-cancer stemness defined by CPTAC proteogenomics guides personalized therapies
Cancer Research·2021
Proteogenomic and metabolomic characterization of human glioblastoma
Cancer Cell·2021· 644 citedOpen Access
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
Cancer Cell·2021· 356 citedOpen Access
Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer
Cell·2020· 318 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Didier Trono(17), Ana I. Robles(14), Li Ding(14), Mehdi Mesri(13), David Fenyö(13), D.R. Mani(13), Antonio Colaprico(12), Bing Zhang(12), Pei Wang(12), Alexey I. Nesvizhskii(12), Chet Birger(12), Gad Getz(11), Boris Reva(11), Tara Hiltke(11), Henry Rodriguez(11), Mathangi Thiagarajan(11), Yize Li(10), Weiping Ma(10), Matthew A. Wyczalkowski(10), Dmitry Rykunov(10)